Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Defu Liu has a total of 70 co-authors. Here are the top co-authors by number of shared publications:

  • Jing-Wen Lin

    Department of Laboratory Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University , Chengdu 610041

    3 shared publications
  • Lu Chen

    Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China

    3 shared publications
  • Zhifeng He

    Department of Laboratory Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University , Chengdu 610041

    3 shared publications
  • Bin Mao

    Department of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, China

    2 shared publications
  • Caoyu Xie

    Guangzhou University of Chinese Medicine

    2 shared publications
  • Chao Tang

    Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Department of Laboratory Medicine West China Second University Hospital Sichuan University Chengdu China

    2 shared publications

Latest Publications

  • Open Access

    scSpAS: an integrated single-cell and spatial atlas of transcript isoform regulation

    by Li Chen, Defu Liu, Zhifeng He, Zijie Xu, Ruihan Li, Qingxin Yang, Zhaoshuo Gao, Ruolan Xia, Junwei Song, Tianyu He, et al.

    Alternative transcript initiation, splicing, and 3′-end processing jointly shape transcript isoform diversity, but these regulatory layers remain fragmented across separate single-cell and spatial resources. Here, we present scSpAS, an integrated database of alternative transcription start site (ATS), alternative splicing, full-length transcript isoforms, and alternative polyadenylation (APA) in human and mouse. It contains 123 datasets, including over 418 000 cells and 82 000 spatial spots across healthy and disease contexts, covering 13 cancer types, 5 infectious conditions, 8 inflammatory diseases, and 90 healthy samples. Based on uniformly standardized pipelines, we utilized 5′ capture and 3′ capture single-cell RNA-sequencing data to identify ATS and APA sites, and the Smart-seq2 and long-read sequencing data to identify the alternative splicing events and isoforms. In total, scSpAS contains >648 000 alternative splicing events, 432 000 ATS, and 621 000 APA sites, as well as over 551 000 transcript isoforms. The database further integrates regulatory annotations derived from CLIP-seq, ATAC-seq, and CAGE-seq, together with predicted splicing regulatory motifs. scSpAS enables users to retrieve events, isoforms and genes, examine differential usage at cell-type and spatial levels, and in different biological and physiological conditions; furthermore, users can inspect the potential regulatory mechanisms of all events. It is freely available at https://scspas.chenlulab.com/.

  • Open Access

    Accurate profiling of single-cell alternative transcript start sites by correcting RNA degradation

    by Zijie Xu, Zhen Zhou, Chao Tang, Yating Zhang, Bin Mao, Yiming Zhang, Li Chen, Dan Zhang, Junwei Song, Xiuran Zheng, et al.

    The generation of transcript variants via alternative utilisation of transcription start sites (TSSs) is a pivotal regulatory mechanism in physiological and pathological states. Recent advancements in 5’ single-cell RNA sequencing (scRNA-seq) have enabled TSS analysis at the single-cell level. However, RNA degradation leads to non-uniform read coverage, posing a critical challenge that significantly compromises accurate TSS quantification of scRNA-seq data. To address RNA degradation and improve TSS quantification, we develop scATS (single-cell alternative transcription start site) to estimate RNA degradation at both isoform and sample levels, and provide TSS quantification with or without degradation correction. Application of scATS reveals dynamic and context-dependent regulation of TSSs in haematopoiesis and disease, providing additional information on TSS isoforms that aids cell clustering at a finer resolution. Furthermore, we establish a machine-learning pipeline, lung cancer relevance score (LRS), to identify TSSs associated with lung cancer. We analyse TSS isoforms of CCR6 , CCR2 and RTKN2 in lung cancer cell lines and confirm that isoforms highly transcribed in lung cancer promote cell proliferation and migration. Combined, we present a robust tool to accurately quantify TSS by accounting for RNA degradation, a common issue that confounds transcript quantification, and experimentally demonstrate the important roles of TSS-mediated gene regulation in tumourigenesis.


  • Simultaneous Profiling and Quantification of Tau and Its Phosphorylated Isomers Using Engineered FraC Nanopores

    by Yu Xin, Defu Liu, Yue Ma, Zhijing Zhang, Peng Chen, Mengze Wu, Yue Li, Shanchuan Chen, Shixin Yan, Guiqin Song, et al.

    Tau aggregation and hyperphosphorylation are key pathological hallmarks and early diagnostic biomarkers of Alzheimer's disease (AD). However, the simultaneous profiling and quantitative analysis of Tau and its phosphorylated isoforms remain technically challenging. Here, by introducing an acidic aspartate residue at the G6 site of FraCG13F, we engineered a high-resolution FraCG6DG13F nanopore with enhanced temporal resolution for protonated polypeptide detection. Integrated with machine-learning algorithms, our nanopore-based workflow enabled the real-time identification of 12 tryptic peptides from native Tau (2N4R) protein with over 91.1% accuracy. Furthermore, positional phosphorylation isomers at either S400 or S402 of Tau (2N4R) were precisely resolved and quantified in mixed digestion samples, achieving classification accuracy exceeding 93% and sensitivity comparable to that of microgram-level mass spectrometry. This study demonstrates a promising advancement of global analysis of phosphorylated Tau in nanopore-based methods, highlighting its potential for high-resolution characterization and accurate quantification of proteins with PTMs.


  • Open Access

    The functional landscape of alternative splicing in hematopoietic lineage commitment

    by Xiao Hu, Jinrui Wang, Li Chen, Qin Yang, Manuel Tardaguila, Bin Mao, Shenghui Niu, Zijie Xu, GuiHua Wang, Dan Zhang, et al.

    Alternative splicing (AS) is a ubiquitous post-transcriptional regulatory mechanism, that has greatly expanded the transcriptomic and proteomic diversity in vertebrates. While gene regulation of hematopoiesis has been extensively researched in vertebrates, the functions of species- and cell lineage-specific splice variants in vertebrates are largely unknown. Here, we curate transcriptomic data on fetal hematopoietic organ development in six vertebrates and hematopoietic cell differentiation in humans and mice. To identify functional exon-skipping events among thousands of cassette exons in protein-coding genes for a specific differentiation lineage and species, we develop a machine-learning model interrogating 19 features including dynamic expression, protein structure, and evolutionary conservation, and integrate them into a single prediction score, named Functional AS Score (FAScore). Using FAScore, we identify four previously-uncharacterized functional AS events in which deletion of the AS exon leads to defects in erythropoiesis and myelopoiesis. Furthermore, we demonstrate that deletion of exon 15 of TBC1D23 reduces erythropoiesis in mice and zebrafish through elevated binding capacity to RANBP2/RANGAP1 leading to increased SUMOylation level of HDAC1 . Collectively, our study presents a valuable tool to identify functional exon skipping (ES) events during hematopoietic lineage commitment, and establishes a research paradigm that can be broadly applied to other biological processes.


  • Open Access

    Development and validation of a hepatocellular carcinoma classifier based on macrophage-related gene set for rapid evaluation of patient response types and prognosis

    by Defu Liu, Jing Yang, Zhanfeng Dai, Zhengjun Wang, Xiaonan Huang, Caoyu Xie

    Tumor-associated macrophages (TAMs) participate in and shape the tumor microenvironment of hepatocellular carcinoma (HCC), which is closely related to the formation of tumor heterogeneity. The aim of this study is to distinguish different subtypes of patients according to the activity level of macrophage functional gene set in HCC. We collected 1203 tissue samples from TCGA, ICGC and GEO databases. Using macrophage-associated gene set (MRRGS) from GSEA database, the score of MRRGS was calculated based on gene set variation analysis (GSVA). The key MRRGS was screened by univariate COX regression analysis and LASSO regression. Finally, non-negative matrix factorization (NMF) was used to classify HCC subtypes. Six immune cell infiltration algorithms, immune checkpoint expression differences, tumor immunity and rejection (TIDE) analysis, mutation data analysis, stem cell index based on mRNA expression (mRNAsi) were used to evaluate and reveal the differences of immunity, mutation and tumor cell malignancy among different HCC subtypes. Weighted gene coexpression network (WGCNA) is used to analyze the functional mechanism involved in MRRGS. CAMP and drug sensitivity analysis are used to explore drugs for different HCC subtypes. Two machine learning algorithms assist in screening characteristic genes among subtypes to facilitate subtype discrimination. Our study divides patients into two subtype (C1 and C2) by defining 12 MRRGS, which are similar to hot and cold tumors mentioned in previous studies. The stability of the macrophage functional classifier was validated in two independent HCC cohorts and this classifier can well predict the ability of patients to respond to immunotherapy, TACE treatment and various drug. Based on the above results, we built a bioinformatics tool to help users quickly distinguish patient subtypes and prognosis. In addition, immune signals (such as PD1-PDL1 signals), mutations, metabolic abnormalities, viral infection and chemical erosion in the environment are important upstream foundations of HCC heterogeneity caused by macrophages. This provides insights into the clinical treatment and management of HCC.

  • Open Access

    Mechanism of a Herbal Formula Associated with Prognosis and Immune Infiltration in LIHC: Transcriptomics Analysis and Molecular Dynamics Simulations

    by Jiankun Xu, Defu Liu, Zhanhua Liu, Jing Yang, Hanrui Chen

    Background. The aim of this study is to explore the interactions between effective monomers of herbal formulas and their therapeutic targets using systems biology approaches which may be a promising approach to unraveling their underlying mechanisms. Shentao Ruangan decoction (STRGD), which has been experimentally, clinically demonstrated to be effective in treating liver hepatocellular carcinoma (LIHC), was selected. Methods. Bioactive ingredients and drug targets of STRGD were retrieved from the traditional Chinese medicine systems pharmacology database and analysis platform and BATMAN-TCM databases. LIHC-related differentially expressed genes (DEGs) and key modules were identified by a weighted gene coexpression network analysis using The Cancer Genome Atlas data. The KaplanMeier analysis was used to investigate the relationship between STRGD tumor targets and patients survival. The CIBERSORT deconvolution algorithm was used to analyze the correlation between STRGD tumor targets and infiltrating immune cells. Enrichment analysis was used to analyze biological functions. Interactions between STRGD compounds and LIHC-immune-related genes were investigated using molecular docking and MDS. Results. We identified 24 STRGD tumor targets, which were found to be correlated with survival and the level of immune cell infiltration in LIHC patients. Immune infiltration, gene set enrichment, and Kyoto Encyclopedia of Genes and Genomes analyses highlighted the roles of T and B cell subsets, which were both related to activator protein 1 (AP1), in STRGD action. Docking studies and HPLC indicated that tanshinone IIA is the main compound of STRGD in LIHC treatment, and MDS showed that the potential LIHC-immune-related targets 1FOS and 1JUN firmly bind to tanshinone IIA. Conclusions. The mechanisms of STRGD in improving the immune and survival status of LIHC patients include interactions between STRGD compounds and LIHC-immune-related targets. The findings of this study can guide research studies on the potential usefulness of tanshinone IIA in the development of drugs targeting 1JUN and 1FOS for the treatment of LIHC.


  • Open Access

    Targets and Potential Mechanism of Scutellaria baicalensis in Treatment of Primary Hepatocellular Carcinoma Based on Bioinformatics Analysis

    by Defu Liu, Zhengjun Wang, Li Zhong, Caoyu Xie, Xiaonan Huang, Yaofeng Zhi, Yuzhuo Zhang, Jiaying Liang, Zhenni Shi, Jin Huang, et al.

    Objective. To analyze the target and potential mechanism of Scutellaria baicalensis (SB) in the treatment of HCC based on bioinformatics, so as to provide suggestions for the diagnosis, treatment, and drug development of hepatocellular carcinoma (HCC). Methods. The regulated gene targets of SB were screened by gene expression pattern clustering and differential analysis of gene expression data of HepG2 cells treated with SB at 0h, 1h, 3h, 6h, 12h, and 24h. The module genes related to HCC were identified by the weighted gene coexpression network analysis (WGCNA). KEGG and GO enrichment were used to analyze the molecular function and structure of the module, and GSEA was used to evaluate the different functional pathways between normal people and patients with HCC. Then, the module gene was used for univariate Cox proportional hazard analysis and the least absolute shrinkage and selection operator (LASSO) Cox regression analysis to build a prognostic model. The protein-protein interaction network (PPI) was used to analyze the core genes regulated by SB (CGRSB) of the module, and the survival curve revealed the CGRSB impact on patient survival. The CIBERSORT algorithm combined with correlation analysis to explore the relationship between CGRSB and immune infiltration. Finally, the single-cell sequencing technique was used to analyze the distribution of CGRSB at the cellular level. Results. SB could regulate 903 genes, of which 234 were related to the occurrence of HCC. The prognosis model constructed by these genes has a good effect in evaluating the survival of patients. KEGG and GO enrichment analysis showed that the regulation of SB on HCC mainly focused on some cell proliferation, apoptosis, and immune-related functions. GSEA enrichment analysis showed that these functions are related to the occurrence of HCC. A total of 24 CGRSB were obtained after screening, of which 13 were significantly related to survival, and most of them were unfavorable factors for patient survival. The correlation analysis of gene expression showed that most of CGRSB was significantly correlated with T cells, macrophages, and other functions. The results of single-cell analysis showed that the distribution of CGRSB in macrophages was the most. Conclusion. SB has high credibility in the treatment of HCC, such as CDK2, AURKB, RRM2, CENPE, ESR1, and PRIM2. These targets can be used as potential biomarkers for clinical diagnosis. The research also shows that the p53 signal pathway, MAPK signal pathway, apoptosis pathway, T cell receptor pathway, and macrophage-mediated tumor immunity play the most important role in the mechanism of SB in treating HCC.


  • Open Access

    Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model

    by Qiaoping Li, Ziwei Huang, Defu Liu, Jingna Zheng, Jianhui Xie, Jiannan Chen, Huifang Zeng, Ziren Su, Yucui Li

    Purpose: Berberine (BBR) is an active component of Phellodendri Cortex (PC), which is a traditional Chinese medicine that has been prescribed clinically for hyperuricemia (HUA) for hundreds of years. Many studies reported the anti-inflammatory and nephroprotective properties of BBR and PC; however, the therapeutic effects of BBR on HUA have not been explored. This study aims to investigate the efficacy and mechanism of BBR for treating HUA. Methods: The mechanism of BBR in the treatment of HUA were predicted by network pharmacology. A mouse model of HUA established by potassium oxonate and hypoxanthine was used to verify the prediction. The levels of serum uric acid (UA), urea nitrogen (BUN) and creatinine (CRE) were determined by biochemical test kits. Hematoxylin and eosin staining of kidney tissues was used to observe the kidney damage. ELISA kits were applied to detect the levels of interleukin (IL)-1β and IL-18 in serum and kidney tissues. Quantitative real-time PCR and Western blotting were adopted to analyze the expression of NLRP3, ASC, Caspase1, IL-1β and URAT1. The expressions of URAT1 in the kidney tubules were visualized by immunohistochemical staining. Molecular docking was used to assess the interaction between URAT1 and BBR. Results: The network pharmacology screened out 82 genes and several inflammation-related signaling pathways related to the anti-hyperuricemia effect of BBR. In the in vivo experiment, BBR substantially decreased the level of UA, BUN and CRE, and alleviated the kidney damage in mice with HUA. BBR reduced IL-1β and IL-18, and downregulated expressions of NLRP3, ASC, Caspase1 and IL-1β. BBR also inhibited expression of URAT1 and exhibited strong affinity with this target in silico docking. Conclusion: BBR exerts anti-HUA and nephroprotective effects via inhibiting activation of NLRP3 inflammasome and correcting the aberrant expression of URAT1 in kidney. BBR might be a novel therapeutic agent for treating HUA.